Screening for Cervical Cancer and Management of Its Precursor Lesions
Author:
Johnson Janice L.
Publisher
Springer New York
Reference33 articles.
1. IARC. Handbooks of cancer prevention, Cervix cancer screening, vol. 10. Lyon: IARC Press; 2005.
2. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810–9.
3. Cuzick J, Clavel C, Perry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095–101.
4. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500–5.
5. Kurman RJ, Henson DE, Herbst AL, et al. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994;271:1866–9.